Finally, Schrag et al (1997) and Grann et al (1998, 2000, 2002) were modelling survival for women with a BRCA1/2 mutation and a family history predisposing them to both breast and ovarian cancer. This evidence concerns the gene BRCA1 and ovarian carcinoma.